Dr. Elaine C. Tozman, MD

Dr. Tozman practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Tozman's NPI, 1679581235, was assigned on August 3, 2006. Dr. Tozman graduated from University of Toronto Faculty of Medicine in 1975. Dr. Tozman holds Florida license ME41109.

Dr. Tozman's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Tozman's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Tozman is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tozman practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tozman's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tozman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tozman's licenses on file in 2 states: Florida and California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Tozman treats.

CMS data shows 526 Medicare services from Dr. Tozman across 6 procedure codes in 2024, for 284 Medicare patients. Medicare paid $32,546 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Tozman in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high cholesterol, and 74% have arthritis. 32% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tozman's median patient age at 63, with 79% women.

In 2024, Dr. Tozman wrote 2,800 Medicare Part D claims for 338 patients. 85% of them were for generic drugs. CMS names the drug for 2,394 of them, across 55 drugs with 11 or more claims each, at $2,009,220 in total drug cost. In 2023, CMS named 2,493 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Tozman for performance year 2024, reported as part of a group. Dr. Tozman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tozman as offering telehealth.

Dmand AI links 15 papers to Dr. Tozman in 2010. The most frequent topics are Lupus Erythematosus, Systemic, Arthritis, Rheumatoid and Corneal Ulcer. Dr. Tozman's most frequent co-authors are Gabriel Nicolas Contreras, MD, MPH, Stephen C. Pflugfelder, MD and Janet L. Davis, MD.

CMS Open Payments shows 37 general payments to Dr. Tozman from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $466.

Dmand AI lists 2 awards for Dr. Tozman, most recently CMS Stage 1 EHR in 2013.

Dr. Tozman graduated from University of Toronto Faculty of Medicine in 1975.

Dr. Tozman is in network with 10 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.